Connect with us

Hi, what are you looking for?

Investing

Investor Webinar, Wednesday 5th Nov, 11:30am AEDT

Locksley Resources Limited (ASX: LKY, OTCQX: LKYRF, FSE: X5L) (“Locksley” or the “Company”), advises that the Company will host an investor webinar to discuss the Company’s recent announcements and the next phase of its U.S expansion strategy.

DATE & TIME: Wednesday, 5th November 2025 at 11:30am AEDT / 8:30am AWST

REGISTRATION LINK: https://janemorganmanagement- au.zoom.us/webinar/register/WN_2qv_ztFDQQqRqr3xkut8DQ

The webinar will cover a series of material updates, including:

  • Receipt of Letter of Interest from the U.S Export-Import Bank (“EXIM”) for up to US$191M in potential project financing support for the Mojave Critical Minerals Project in California.1
  • Commencement of the high-resolution heli-mag and radiometrics survey to accelerate drill targeting across the Mojave Project, California.2
  • Mobilisation of the Diamond Drill rig for the upcoming El-Campo Rare Earths Program, positioned along strike from MP Materials’ Mountain Pass Mine.3
  • Production of a 100% American-made antimony ingot in decades, validating the Company’s U.S Mine-to-Metal supply chain strategy.4

Newly appointed Managing Director & CEO, Ms. Kerrie Matthews5 will present on these milestones and discuss Locksley’s next-phase growth plan and U.S strategy.

Click here for the full ASX Release

This post appeared first on investingnews.com

You May Also Like

Investing

Rio Silver Inc. (‘Rio Silver’ or the ‘Company’) (TSX.V: RYO,OTC:RYOOD) (OTC: RYOOF), announces it has received ‘Conditional Approval’ from the TSX Venture Exchange to...

Investing

Apollo Silver Corp. (‘ Apollo Silver ‘ or the ‘ Company ‘) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) is pleased to announce the Company has closed the...

Latest News

European Commission President Ursula von der Leyen survived a no-confidence vote in the European Parliament on Thursday, brought by mainly far-right lawmakers who alleged...

Economy

Kimberly-Clark said on Monday it will buy Tylenol maker Kenvue KVUE.N in a cash-and-stock deal valued at about $48.7 billion, to create one of...